Intracranial infection due to non-typhoidal Salmonella: report of four cases.
Bellamy
R
R
Barkham
T
T
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D002443:Ceftriaxone / Q000627:therapeutic use; D020806:Central Nervous System Bacterial Infections / Q000150:complications / Q000188:drug therapy / Q000382:microbiology*; D002511:Cephalosporins / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D012480:Salmonella Infections / Q000150:complications / Q000188:drug therapy / Q000382:microbiology*; D012477:Salmonella enteritidis / Q000302:isolation & purification*; D012486:Salmonella typhimurium / Q000302:isolation & purification*
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D002511:Cephalosporins; D005839:Gentamicins; D002939:Ciprofloxacin; D002443:Ceftriaxone